vs
Apellis Pharmaceuticals, Inc.（APLS）与OIL STATES INTERNATIONAL, INC（OIS）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是OIL STATES INTERNATIONAL, INC的1.1倍（$199.9M vs $178.5M），Apellis Pharmaceuticals, Inc.净利率更高（-29.5% vs -65.7%，领先36.2%），OIL STATES INTERNATIONAL, INC同比增速更快（8.4% vs -5.9%），OIL STATES INTERNATIONAL, INC自由现金流更多（$47.1M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 3.3%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
石油国家国际公司是一家美国跨国企业，核心业务是为油气行业企业提供专业相关服务，目前是在纽约证券交易所上市的公众公司。
APLS vs OIS — 直观对比
营收规模更大
APLS
是对方的1.1倍
$178.5M
营收增速更快
OIS
高出14.4%
-5.9%
净利率更高
APLS
高出36.2%
-65.7%
自由现金流更多
OIS
多$61.4M
$-14.3M
两年增速更快
APLS
近两年复合增速
3.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $178.5M |
| 净利润 | $-59.0M | $-117.2M |
| 毛利率 | — | 10.9% |
| 营业利润率 | -25.6% | -63.7% |
| 净利率 | -29.5% | -65.7% |
| 营收同比 | -5.9% | 8.4% |
| 净利润同比 | -62.2% | -873.2% |
| 每股收益（稀释后） | $-0.40 | $-1.99 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSOIS
| Q4 25 | $199.9M | $178.5M | ||
| Q3 25 | $458.6M | $165.2M | ||
| Q2 25 | $178.5M | $165.4M | ||
| Q1 25 | $166.8M | $159.9M | ||
| Q4 24 | $212.5M | $164.6M | ||
| Q3 24 | $196.8M | $174.3M | ||
| Q2 24 | $199.7M | $186.4M | ||
| Q1 24 | $172.3M | $167.3M |
净利润APLSOIS
| Q4 25 | $-59.0M | $-117.2M | ||
| Q3 25 | $215.7M | $1.9M | ||
| Q2 25 | $-42.2M | $2.8M | ||
| Q1 25 | $-92.2M | $3.2M | ||
| Q4 24 | $-36.4M | $15.2M | ||
| Q3 24 | $-57.4M | $-14.3M | ||
| Q2 24 | $-37.7M | $1.3M | ||
| Q1 24 | $-66.4M | $-13.4M |
毛利率APLSOIS
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 22.1% | ||
| Q2 25 | — | 24.2% | ||
| Q1 25 | — | 23.3% | ||
| Q4 24 | — | 23.7% | ||
| Q3 24 | — | 21.7% | ||
| Q2 24 | — | 23.8% | ||
| Q1 24 | — | 21.1% |
营业利润率APLSOIS
| Q4 25 | -25.6% | -63.7% | ||
| Q3 25 | 48.7% | 2.9% | ||
| Q2 25 | -18.6% | 3.2% | ||
| Q1 25 | -50.0% | 3.5% | ||
| Q4 24 | -12.3% | 11.2% | ||
| Q3 24 | -24.0% | -6.3% | ||
| Q2 24 | -14.7% | 1.1% | ||
| Q1 24 | -36.0% | -6.7% |
净利率APLSOIS
| Q4 25 | -29.5% | -65.7% | ||
| Q3 25 | 47.0% | 1.2% | ||
| Q2 25 | -23.6% | 1.7% | ||
| Q1 25 | -55.3% | 2.0% | ||
| Q4 24 | -17.1% | 9.2% | ||
| Q3 24 | -29.2% | -8.2% | ||
| Q2 24 | -18.9% | 0.7% | ||
| Q1 24 | -38.5% | -8.0% |
每股收益（稀释后）APLSOIS
| Q4 25 | $-0.40 | $-1.99 | ||
| Q3 25 | $1.67 | $0.03 | ||
| Q2 25 | $-0.33 | $0.05 | ||
| Q1 25 | $-0.74 | $0.05 | ||
| Q4 24 | $-0.30 | $0.24 | ||
| Q3 24 | $-0.46 | $-0.23 | ||
| Q2 24 | $-0.30 | $0.02 | ||
| Q1 24 | $-0.54 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $69.9M |
| 总债务越低越好 | — | $1.7M |
| 股东权益账面价值 | $370.1M | $573.2M |
| 总资产 | $1.1B | $883.4M |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资APLSOIS
| Q4 25 | $466.2M | $69.9M | ||
| Q3 25 | $479.2M | $67.1M | ||
| Q2 25 | $370.0M | $53.9M | ||
| Q1 25 | $358.4M | $66.8M | ||
| Q4 24 | $411.3M | $65.4M | ||
| Q3 24 | $396.9M | $46.0M | ||
| Q2 24 | $360.1M | $25.2M | ||
| Q1 24 | $325.9M | $24.1M |
总债务APLSOIS
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $124.7M | ||
| Q4 24 | — | $124.7M | ||
| Q3 24 | — | $124.6M | ||
| Q2 24 | — | $124.3M | ||
| Q1 24 | $93.1M | $135.6M |
股东权益APLSOIS
| Q4 25 | $370.1M | $573.2M | ||
| Q3 25 | $401.2M | $689.0M | ||
| Q2 25 | $156.3M | $690.6M | ||
| Q1 25 | $164.2M | $683.4M | ||
| Q4 24 | $228.5M | $680.7M | ||
| Q3 24 | $237.1M | $684.8M | ||
| Q2 24 | $264.3M | $690.4M | ||
| Q1 24 | $266.7M | $692.3M |
总资产APLSOIS
| Q4 25 | $1.1B | $883.4M | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $821.4M | $993.7M | ||
| Q1 25 | $807.3M | $990.7M | ||
| Q4 24 | $885.1M | $1.0B | ||
| Q3 24 | $901.9M | $994.1M | ||
| Q2 24 | $904.5M | $1.0B | ||
| Q1 24 | $831.9M | $1.0B |
负债/权益比APLSOIS
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.18× | ||
| Q1 24 | 0.35× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $50.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $47.1M |
| 自由现金流率自由现金流/营收 | -7.1% | 26.4% |
| 资本支出强度资本支出/营收 | 0.1% | 1.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $73.9M |
8季度趋势，按日历期对齐
经营现金流APLSOIS
| Q4 25 | $-14.2M | $50.1M | ||
| Q3 25 | $108.5M | $30.7M | ||
| Q2 25 | $4.4M | $15.0M | ||
| Q1 25 | $-53.4M | $9.3M | ||
| Q4 24 | $19.4M | $18.2M | ||
| Q3 24 | $34.1M | $28.8M | ||
| Q2 24 | $-8.3M | $10.2M | ||
| Q1 24 | $-133.0M | $-11.4M |
自由现金流APLSOIS
| Q4 25 | $-14.3M | $47.1M | ||
| Q3 25 | $108.3M | $22.0M | ||
| Q2 25 | $4.4M | $4.7M | ||
| Q1 25 | $-53.4M | $137.0K | ||
| Q4 24 | $19.3M | $4.0M | ||
| Q3 24 | — | $21.4M | ||
| Q2 24 | $-8.4M | $4.5M | ||
| Q1 24 | $-133.3M | $-21.5M |
自由现金流率APLSOIS
| Q4 25 | -7.1% | 26.4% | ||
| Q3 25 | 23.6% | 13.3% | ||
| Q2 25 | 2.5% | 2.8% | ||
| Q1 25 | -32.0% | 0.1% | ||
| Q4 24 | 9.1% | 2.4% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | -4.2% | 2.4% | ||
| Q1 24 | -77.3% | -12.8% |
资本支出强度APLSOIS
| Q4 25 | 0.1% | 1.7% | ||
| Q3 25 | 0.0% | 5.3% | ||
| Q2 25 | 0.0% | 6.2% | ||
| Q1 25 | 0.0% | 5.7% | ||
| Q4 24 | 0.0% | 8.6% | ||
| Q3 24 | 0.0% | 4.3% | ||
| Q2 24 | 0.0% | 3.1% | ||
| Q1 24 | 0.2% | 6.0% |
现金转化率APLSOIS
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 16.15× | ||
| Q2 25 | — | 5.33× | ||
| Q1 25 | — | 2.94× | ||
| Q4 24 | — | 1.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 7.87× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
OIS
| Project Driven | $112.6M | 63% |
| Downhole Technologies | $32.1M | 18% |
| Completion And Production Services | $23.1M | 13% |
| Military And Other Products | $10.7M | 6% |
